Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Tracon Pharmaceuticals Inc (TCON)

Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Tracon: Q1 Earnings Snapshot AP - Tue May 14, 3:10PM CDT

Tracon: Q1 Earnings Snapshot

TCON : 0.6301 (+4.84%)
Tracon: Q4 Earnings Snapshot AP - Tue Mar 5, 3:59PM CST

Tracon: Q4 Earnings Snapshot

TCON : 0.6301 (+4.84%)
Tracon: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Tracon: Q3 Earnings Snapshot

TCON : 0.6301 (+4.84%)
Tracon: Q2 Earnings Snapshot AP - Mon Aug 14, 2023

Tracon: Q2 Earnings Snapshot

TCON : 0.6301 (+4.84%)
Tracon: Q1 Earnings Snapshot AP - Wed May 10, 2023

Tracon: Q1 Earnings Snapshot

TCON : 0.6301 (+4.84%)
Tracon: Q4 Earnings Snapshot AP - Wed Mar 8, 2023

Tracon: Q4 Earnings Snapshot

TCON : 0.6301 (+4.84%)
Tracon: Q3 Earnings Snapshot AP - Mon Nov 14, 2022

Tracon: Q3 Earnings Snapshot

TCON : 0.6301 (+4.84%)
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab Business Wire - Mon Aug 29, 2022

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the...

TCON : 0.6301 (+4.84%)
TRACON Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Wed Aug 10, 2022

SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...

TCON : 0.6301 (+4.84%)
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial Globe Newswire - Wed Aug 10, 2022

Trial to Continue as Planned...

TCON : 0.6301 (+4.84%)

Barchart Exclusives

2 Penny Stocks Wall Street Expects to Soar Over 400% Barchart - Mon Jul 22, 12:12PM CDT
These two penny stock companies, while risky and volatile, have the potential to generate massive returns, according to Wall Street's price forecasts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot